OpenAlex
PricingAboutJobs
Log inGet started
Work

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

HTML

Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Respiratory Journal
DOI: 10.1183/09031936.00137511
Authors: Gérald Simonneau, Adam Torbicki, Marius M. Hoeper, Marion Delcroix, Kristóf Karlócai, Nazzareno Galiè, Bruno Degano, Diana Bonderman, Marcin Kurzyna, Michela Efficace, Ruben Giorgino, Irene M. Lang
Institutions: Hôpital Antoine-Béclère, Medizinische Hochschule Hannover, Universitair Ziekenhuis Leuven, Semmelweis University, University of Bologna, Assistance Publique – Hôpitaux de Paris, Medical University of Vienna, Actelion (Switzerland)
Language: English

Topic: Pulmonary Hypertension Research and Treatments
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: selexipag, prostacyclin receptor agonist, IP receptor, pulmonary arterial hypertension, pulmonary vascular resistance, oral therapy, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, drug safety, drug efficacy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2102522559
FWCI: 25.48
Cites: 25
Cited by: 348
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms